I'm LongbridgeAI, I can summarize articles.Maccura announced that it will transfer its 51% stake in Shandong Maccura to Han Siguang for a price of 17.413 million yuan. This move aims to optimize resource allocation, focus on core business, and enhance market competitiveness. After the transfer, the company will establish an office to manage distributors in the region and continue to expand its market coverage in Shandong. It is expected that this transfer will not have a significant impact on the company's main business
According to the Zhitong Finance APP, Maccura (300463.SZ) announced that with the clarification of the company's strategic positioning and changes in the market environment, in order to further focus on core business, optimize resource allocation, enhance the company's market competitiveness and operational quality, and accelerate the adjustment of regional direct sales and distribution business, the company plans to transfer 51% of its equity in its holding subsidiary Shandong Maccura Biotechnology Co., Ltd. (hereinafter referred to as "Shandong Maccura") to Han Siguang at a transaction price of RMB 17.413 million.
After the completion of this equity transfer, the company will no longer hold equity in Shandong Maccura. The company will establish an office in Shandong and manage and expand regional distributors through the office, continuously covering and expanding the Shandong regional market. This equity transfer will not have a significant impact on the company's main business operations